211 related articles for article (PubMed ID: 37200193)
1. Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells.
Xu W; Qadir MMF; Nasteska D; Mota de Sa P; Gorvin CM; Blandino-Rosano M; Evans CR; Ho T; Potapenko E; Veluthakal R; Ashford FB; Bitsi S; Fan J; Bhondeley M; Song K; Sure VN; Sakamuri SSVP; Schiffer L; Beatty W; Wyatt R; Frigo DE; Liu X; Katakam PV; Arlt W; Buck J; Levin LR; Hu T; Kolls J; Burant CF; Tomas A; Merrins MJ; Thurmond DC; Bernal-Mizrachi E; Hodson DJ; Mauvais-Jarvis F
Cell Rep; 2023 May; 42(5):112529. PubMed ID: 37200193
[TBL] [Abstract][Full Text] [Related]
2. Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.
Navarro G; Xu W; Jacobson DA; Wicksteed B; Allard C; Zhang G; De Gendt K; Kim SH; Wu H; Zhang H; Verhoeven G; Katzenellenbogen JA; Mauvais-Jarvis F
Cell Metab; 2016 May; 23(5):837-51. PubMed ID: 27133133
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.
Xu W; Niu T; Xu B; Navarro G; Schipma MJ; Mauvais-Jarvis F
J Diabetes Complications; 2017 May; 31(5):787-795. PubMed ID: 28343791
[TBL] [Abstract][Full Text] [Related]
4. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
[TBL] [Abstract][Full Text] [Related]
5. Exogenous and endogenous ghrelin counteracts GLP-1 action to stimulate cAMP signaling and insulin secretion in islet β-cells.
Damdindorj B; Dezaki K; Kurashina T; Sone H; Rita R; Kakei M; Yada T
FEBS Lett; 2012 Jul; 586(16):2555-62. PubMed ID: 22750144
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
[TBL] [Abstract][Full Text] [Related]
7. Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity.
Miguel JC; Abdel-Wahab YH; Green BD; Mathias PC; Flatt PR
Biochem Pharmacol; 2003 Jan; 65(2):283-92. PubMed ID: 12504804
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
9. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.
Roger B; Papin J; Vacher P; Raoux M; Mulot A; Dubois M; Kerr-Conte J; Voy BH; Pattou F; Charpentier G; Jonas JC; Moustaïd-Moussa N; Lang J
Diabetologia; 2011 Feb; 54(2):390-402. PubMed ID: 21046358
[TBL] [Abstract][Full Text] [Related]
10. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
Lee YS; Jun HS
Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
[TBL] [Abstract][Full Text] [Related]
12. SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.
Nie J; Lilley BN; Pan YA; Faruque O; Liu X; Zhang W; Sanes JR; Han X; Shi Y
Mol Cell Biol; 2013 Jul; 33(13):2527-34. PubMed ID: 23629625
[TBL] [Abstract][Full Text] [Related]
13. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
16. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
[TBL] [Abstract][Full Text] [Related]
17. Glucose- and hormone-induced cAMP oscillations in α- and β-cells within intact pancreatic islets.
Tian G; Sandler S; Gylfe E; Tengholm A
Diabetes; 2011 May; 60(5):1535-43. PubMed ID: 21444924
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
19. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
20. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
